IL-6 signaling pathways occur early in the inflammatory cascade with subsequent downstream effects on insulin-signaling molecules and insulin pathways (e.g., IGF-1), which may be related to weight gain, recurrence, and survival of patient with breast cancer. This evidence concerns the gene IGF1 and breast cancer.